Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection

被引:288
|
作者
Hausenloy, D
Wynne, A
Duchen, M
Yellon, D
机构
[1] UCL, Hatter Inst, London WC1E 6DB, England
[2] UCL, Ctr Cardiol, London WC1E 6DB, England
[3] UCL, Dept Physiol, Mitochondrial Biol Grp, London WC1E 6BT, England
关键词
ischemia; myocardial infarction; free radicals; reperfusion;
D O I
10.1161/01.CIR.0000126294.81407.7D
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Transient (low-conductance) opening of the mitochondrial permeability transition pore (mPTP) may limit mitochondrial calcium load and mediate mitochondrial reactive oxygen species (ROS) signaling. We hypothesize that transient mPTP opening and ROS mediate the protection associated with myocardial preconditioning and mitochondrial uncoupling. Methods and Results - Isolated perfused rat hearts were subjected to 35 minutes of ischemia/ 120 minutes of reperfusion, and the infarct-risk-volume ratio was determined by tetrazolium staining. Inhibiting mPTP opening during the preconditioning phase with cyclosporine-A (CsA, 0.2 mumol/L) or sanglifehrin-A (SfA, 1.0 mumol/L) abolished the protection associated with ischemic preconditioning (IPC) ( 20.2 +/- 3.6% versus 45.9 +/- 2.5% with CsA, 49.0 +/- 7.1% with SfA; P < 0.001); and pharmacological preconditioning with diazoxide (Dzx, 30 mu mol/L) (22.1 +/- 2.7% versus 46.3 +/- 3.0% with CsA, 48.4 +/- 5.5% with SfA; P < 0.001), CCPA ( the adenosine A1-receptor agonist, 200 nmol/L) (24.9 +/- 4.5% versus 54.4 +/- 6.6% with CsA, 42.6 +/- 9.0% with SfA; P < 0.001), or 2,4-dinitrophenol (DNP, the mitochondrial uncoupler, 50 mu mol/L) (15.7 +/- 2.7% versus 40.8 +/- 5.5% with CsA, 34.3 +/- 3.1% with SfA; P < 0.001), suggesting that mPTP opening during the preconditioning phase is required to mediate protection in these settings. Inhibiting ROS during the preconditioning protocols with N-mercaptopropionylglycine (MPG, 1 mmol/L) also abolished the protection associated with IPC (20.2 +/- 3.6% versus 47.1 +/- 3.8% with MPG; P < 0.001), diazoxide (22.1 +/- 2.7% versus 56.3 +/- 3.8% with MPG; P < 0.001), and DNP (15.7 +/- 2.7% versus 50.7 +/- 6.6% with MPG; P < 0.001) but not CCPA (24.9 +/- 4.5% versus 26.5 +/- 8.4% with MPG; P = NS). Further experiments in adult rat myocytes demonstrated that diazoxide induced CsA-sensitive, low-conductance transient mPTP opening (represented by a 28 +/- 3% reduction in mitochondrial calcein fluorescence compared with control; P < 0.01). Conclusions - We report that the protection associated with IPC, diazoxide, and mitochondrial uncoupling requires transient mPTP opening and ROS.
引用
收藏
页码:1714 / 1717
页数:4
相关论文
共 50 条
  • [21] Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion
    Kerstin Boengler
    Denise Hilfiker-Kleiner
    Gerd Heusch
    Rainer Schulz
    Basic Research in Cardiology, 2010, 105 : 771 - 785
  • [22] Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion
    Boengler, Kerstin
    Hilfiker-Kleiner, Denise
    Heusch, Gerd
    Schulz, Rainer
    BASIC RESEARCH IN CARDIOLOGY, 2010, 105 (06) : 771 - 785
  • [23] A glibenclamide analog lacking the cyclohexylurea portion fails to block ischemic preconditioning-induced mitochondrial and cardiac protection against ischemia/reperfusion injury
    Palacio, Plinio Bezerra
    Soares, Geovanna Carvalho de Freitas
    Facundo, Heberty Tarso
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2025, 769
  • [24] Effects of Anesthesia with Pentobarbital/Ketamine on Mitochondrial Permeability Transition Pore Opening and Ischemic Brain Damage
    Rekuviene, Evelina
    Ivanoviene, Laima
    Borutaite, Vilmante
    Morkuniene, Ramune
    BIOMEDICINES, 2024, 12 (10)
  • [25] A critical review of mechanisms regulating remote preconditioning-induced brain protection
    Meller, Robert
    Simon, Roger P.
    JOURNAL OF APPLIED PHYSIOLOGY, 2015, 119 (10) : 1135 - 1142
  • [26] Pharmacology of mitochondrial permeability transition pore inhibitors
    Naryzhnaya, Natalia V.
    Maslov, Leonid N.
    Oeltgen, Peter R.
    DRUG DEVELOPMENT RESEARCH, 2019, 80 (08) : 1013 - 1030
  • [27] Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis
    Shi, Hongwei
    Tang, Heng
    Ai, Wen
    Zeng, Qingfu
    Yang, Hong
    Zhu, Fengqing
    Wei, Yunjie
    Feng, Rui
    Wen, Li
    Pu, Peng
    He, Quan
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [28] Propofol Attenuates the Myocardial Protection Properties of Desflurane by Modulating Mitochondrial Permeability Transition
    Heiberg, Johan
    Royse, Colin F.
    Royse, Alistair G.
    Andrews, David T.
    ANESTHESIA AND ANALGESIA, 2018, 127 (02) : 387 - 397
  • [29] Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening
    Gurpreet S. Bhamra
    Derek J. Hausenloy
    Sean M. Davidson
    Richard D. Carr
    Marta Paiva
    Abigail M. Wynne
    Mihaela M. Mocanu
    Derek M. Yellon
    Basic Research in Cardiology, 2008, 103 : 274 - 284
  • [30] Opening of the Mitochondrial Permeability Transition Pore Mediated Myocardial Damage After Perinatal Asphyxia in Neonatal Rats
    Chen, Zhixin
    Chen, Jianqin
    Chen, Yongheng
    Fang, Xiaoyi
    FETAL AND PEDIATRIC PATHOLOGY, 2025,